Angiodynamics (ANGO) Accounts Payables (2011 - 2026)

Angiodynamics' Accounts Payables history runs 16 years deep, the most recent figure standing at $31.5 million for Q2 2026.

• Quarterly Accounts Payables fell 5.34% year-over-year to $31.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $31.5 million (down 5.34% YoY) and the FY2026 annual result came in at $31.5 million, down 5.34% from the prior year.
• Accounts Payables was $31.5 million for Q2 2026 at Angiodynamics, up from $29.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $40.4 million in Q2 2023 and bottomed at $21.6 million in Q1 2022.
• A 5-year average of $32.4 million and a median of $32.6 million in 2025 frame the typical range for Accounts Payables.
• Peak annual rise in Accounts Payables reached 65.04% in 2023, while the deepest fall reached 15.21% in 2023.
• Angiodynamics' Accounts Payables stood at $34.7 million in 2022, then rose by 8.54% to $37.6 million in 2023, then retreated by 7.71% to $34.7 million in 2024, then gained by 1.85% to $35.4 million in 2025, then slipped by 10.96% to $31.5 million in 2026.
• Business Quant data shows ANGO's Accounts Payables at $31.5 million in Q2 2026, $29.1 million in Q1 2026, and $35.4 million in Q4 2025.